Stockholders’ equity (Details Narrative) - USD ($)				1 Months Ended	12 Months Ended
		Dec. 09, 2024	Feb. 13, 2024	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Nov. 22, 2024	Jun. 15, 2023	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Issue of shares of capital stock				400,000,000	400,000,000
Common stock, shares authorized				300,000,000	300,000,000	300,000,000
Preferred stock, shares authorized				100,000,000	100,000,000	100,000,000
Proceeds from Issuance of Common Stock					$ 6,832,973	$ 1,000,000
Equity issuance cost						303,281
Offering costs				$ 863,744	863,744
Issuance of common stock, value					$ 6,832,973	$ 910,000
Number of options, outstanding					2,370,170
Weighted average fair value per share					$ 3.83
Weighted average exercise price, outstanding				$ 5.02	$ 5.02
Number of options, exercisable					2,352,670
Stock-based compensation					$ 6,900,000
Unrecognized compensation costs				$ 2,200,000	$ 2,200,000
2023 Omnibus Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock are reserved for issuance						6,500,000
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Equity issuance cost			$ 200,000
Weighted average exercise price, outstanding				$ 4.97	$ 4.97	$ 4.85
Share based compensation term of years	[1]				3 years 5 months 26 days
Placement Agent [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase of common stock						67,007
Exercise price						$ 3.73
Board of Directors, Executive Officers, Employees and Consultants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options, outstanding					2,370,170
Share based compensation fair market value					$ 9,100,000
Weighted average exercise price, outstanding				$ 5.02	$ 5.02
Share based compensation term of years					10 years
Starwood Trust [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net, shares		142,857
Initial public offering shares		$ 7
Proceeds from Issuance of Common Stock		$ 1,000,000.0
Bay Shore Trust [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net, shares				10,000
Exercise price				$ 3.73	$ 3.73			$ 3.73
Fair value of total warrants issued				10,000	10,000	2,439,025	100,000	2,439,025
Exercise price								5 years
Deferred financing costs								$ 5,950,000
Issuance of common stock, value				$ 37,300
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued						268,025
Net proceeds						$ 900,000
Purchase of common stock						268,025
Exercise price						$ 15.42
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, net, shares			1,000,000
Initial public offering shares			$ 7.00
Gross proceeds			$ 7,000,000.0
Underwriting commission and other offering expenses			1,200,000
Initial public offering net proceeds			$ 5,800,000
IPO [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price			$ 7.00
Fair value of total warrants issued			50,000

[1] The warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust that have a remaining contractual term of 3.5 years as of December 31, 2024, 335,032 warrants issued to investors associated with the 2023 Private Placement that currently have an indeterminable contractual term, and 50,000 warrants issued to underwriters as part of the IPO with a remaining contractual life of 3.2 years. See disclosures below for more information on these warrants